These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 18768040

  • 1. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
    Williams GD, Ramamoorthy C, Pentcheva K, Boltz MG, Kamra K, Reddy VM.
    Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
    [Abstract] [Full Text] [Related]

  • 2. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA, Evans FM, Rosenberg ES, Fazlollah TM, Baker MJ, Wilson EC, Kaiser AM, Tosone SR, Miller BE.
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [Abstract] [Full Text] [Related]

  • 3. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM, Jackson LR, Chatwin C, Smolich JJ.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, Mehlhorn U.
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [Abstract] [Full Text] [Related]

  • 9. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O.
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [Abstract] [Full Text] [Related]

  • 10. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience.
    Bojan M, Boulat C, Peperstraete H, Pouard P.
    Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677
    [Abstract] [Full Text] [Related]

  • 11. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O.
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB, Lemke J, Lange M, Rastan A, Mohr FW.
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [Abstract] [Full Text] [Related]

  • 15. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A, Mateo J, Oliver A, Litvan H, Murillo J, Souto JC, Fontcuberta J.
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [Abstract] [Full Text] [Related]

  • 16. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L.
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.
    Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.